How Early Is Early Enough to Reverse MASLD?

Drs VanWagner and Chen discuss whether fatty liver is reversible, weight-loss targets, diet quality, exercise, and where GLP-1s and bariatric surgery fit into MASLD treatment.

Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-masld-s1-ep4-2026a1000aaw. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Resources

Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis https://reference.medscape.com/cc2/p10/global-consensus-recommendations-metabolic-dysfunction-2025a1000iy5#1

Steatotic Liver Disease (SLD) https://emedicine.medscape.com/article/175472-overview

Two-Year Mediterranean Diet Intervention Improves Hepatic Health in MASLD Patients https://pubmed.ncbi.nlm.nih.gov/40428516/

An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in Humans https://pubmed.ncbi.nlm.nih.gov/29456073/

Intermittent Fasting Improves Hepatic End Points in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis https://pubmed.ncbi.nlm.nih.gov/37534936/

Effect of 5:2 Intermittent Fasting Diet Versus Daily Calorie Restriction Eating on Metabolic-Associated Fatty Liver Disease — A Randomized Controlled Trial https://pubmed.ncbi.nlm.nih.gov/39229586/

Physical Activity Compared to Adiposity and Risk of Liver-Related Mortality: Results From Two Prospective, Nationwide Cohorts https://pubmed.ncbi.nlm.nih.gov/31954204/

Adult Activity: An Overview https://www.cdc.gov/physical-activity-basics/guidelines/adults.html

Positive Effects of Exercise Intervention Without Weight Loss and Dietary Changes in NAFLD-Related Clinical Parameters: A Systematic Review and Meta-Analysis https://pubmed.ncbi.nlm.nih.gov/34579012/

Phase 3 ESSENCE Trial: Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis https://pubmed.ncbi.nlm.nih.gov/39896971/

Bariatric Surgery Reduces Long-Term Mortality in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease and Cirrhosis https://pubmed.ncbi.nlm.nih.gov/39541951/

Endoscopic Bariatric Therapies for Metabolic Dysfunction-Associated Steatotic Liver Disease: Mechanistic Insights and Metabolic Implications https://pubmed.ncbi.nlm.nih.gov/41153720/

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.